Increased Serum GLO-1 Levels Are Associated With the Pathophysiology and Development of Obsessive-Compulsive...

Area of Science:

• Neuroscience
• Biochemistry
• Psychiatry

Background:

• Obsessive-compulsive disorder (OCD) is a neuropsychiatric condition characterized by intrusive thoughts and repetitive behaviors.
• The enzyme Glyoxalase-1 (GLO-1) is implicated in various psychiatric disorders, but its specific role in OCD pathogenesis is not well understood.

Purpose of the Study:

• To investigate serum GLO-1 levels in individuals with OCD compared to healthy controls (HCs).
• To explore the potential association between GLO-1 levels and OCD symptom severity.

Main Methods:

• A case-control study involving 35 OCD patients and 35 HCs matched for demographic factors.
• OCD diagnosis and severity assessment using DSM-5 criteria and the Yale-Brown Obsessive Compulsive Scale (Y-BOCS).
• Serum GLO-1 levels were quantified using commercially available ELISA kits.

Main Results:

• OCD patients exhibited significantly elevated serum GLO-1 levels compared to HCs (p=0.032).
• A positive correlation was observed between higher serum GLO-1 levels and increased OCD symptom severity (r=0.724, p<0.001).
• Receiver operating characteristic (ROC) analysis indicated good diagnostic potential for serum GLO-1 in OCD detection (AUC=0.839).

Conclusions:

• Elevated serum GLO-1 levels may play a role in the pathophysiology of OCD.
• Serum GLO-1 could potentially serve as a biomarker for OCD risk assessment.
• Further research in larger, diverse populations is warranted to validate these findings and explore therapeutic implications.